Plain-English translation of NCT07296081 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study looking at a new imaging technique called 68Ga-FAPI PET/CT that may be better at detecting active scarring (fibrosis) in the heart of people with heart failure. Researchers will compare this new scan to the standard heart imaging test (cardiac MRI) to see if it can spot scarring earlier and distinguish between old and active scarring. The goal is to develop better tools for monitoring heart health and testing future heart treatments.
Heart scarring is a major driver of heart failure and getting worse over time, but current imaging methods cannot tell the difference between old scarring and active, ongoing scarring. This new scan may fill that gap, helping doctors better understand which patients need treatment and whether treatments are actually working.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will come to the hospital or clinic for imaging appointments. You will undergo the new 68Ga-FAPI PET/CT scan (a special imaging test that takes pictures of your heart) and have your results compared with your recent cardiac MRI scan. The study team will also look at your blood work and track any heart-related events. The study is observational, meaning you won't be taking new medications—researchers are just testing whether this new imaging tool works better than the current standard.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Portugal